Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Clinical Orthopaedics and Related Research|February 2, 2023
Does PARP Inhibition Sensitize Chondrosarcoma Cell Lines to Chemotherapy or Radiotherapy? Results From a Three-dimensional Spheroid Cell ModelIeva Palubeckaitė, Sanne Venneker, Brendy E W M van den Akker, et al.Journal of Mass Spectrometry : JMS|October 27, 2019
Mass spectrometry imaging of endogenous metabolites in response to doxorubicin in a novel 3D osteosarcoma cell culture modelIeva Palubeckaitė, Lucy Crooks, David P Smith, et al.Frontiers in Molecular Biosciences|January 11, 2021
Selection of Effective Therapies Using Three-Dimensional in vitro Modeling of ChondrosarcomaIeva Palubeckaitė, Sanne Venneker, Inge H Briaire-de Bruijn, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|December 18, 2021
A murine mesenchymal stem cell model for initiating events in osteosarcomagenesis points to CDK4/CDK6 inhibition as a therapeutic targetNatasja Franceschini, Raffaele Gaeta, Paul Krimpenfort, et al.International Journal of Molecular Sciences|July 2, 2021
Targeting the NAD Salvage Synthesis Pathway as a Novel Therapeutic Strategy for Osteosarcomas with Low NAPRT ExpressionNatasja Franceschini, Jan Oosting, Maud Tamsma, et al.Cancers|October 14, 2022
Histone Deacetylase Inhibitors as a Therapeutic Strategy to Eliminate Neoplastic "Stromal" Cells from Giant Cell Tumors of BoneSanne Venneker, Robin van Eenige, Alwine B Kruisselbrink, et al.Frontiers in Medicine|April 2, 2026
Osteosarcoma 3D patient derived cultures to test genome-informed personalized treatment options: a feasibility studyIeva Palubeckaitė, Sanne Venneker, Natasja Franceschini, et al.Neoplasia (New York, N.Y.)|May 5, 2025
Establishment of patient-derived 3D in vitro models of sarcomas: literature review and guidelines on behalf of the FORTRESS working groupLore De Cock, Ieva Palubeckaitė, Francesca Bersani, et al.Neoplasia (New York, N.Y.)|July 27, 2026
Targeting vulnerabilities in IDH mutant tumours: The model mattersAlwine B Kruisselbrink, Tessa A H Wilpshaar, Ieva Palubeckaitė, et al.Pageof 1